Skip to main content
OpenTrials
Completed

NCT Number: NCT02505516

BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS

patients om metformin from diabetic clinic were checked for bladder cancer

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 150 people attending diabetic clinic

Exclusion criteria

Treatment and study plan

Metformin

Other

Other names: glucophage

Primary outcomes

  1. Number of diabetic patients on metformin therapy

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

UFUOMA MILLER FAKPOR

Other

Registry information

Official study title

BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS ON METFORMIN THERAPY IN A WEST AFRICA SUB-REGION

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Jul 22, 2015
Registry last updated
Jul 22, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.